- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mass Casualty Incidents in Belgium
Total 20 results
-
Universitaire Ziekenhuizen KU LeuvenCompletedStrength Training | Muscle Strength, Muscle Mass, Inflammatory ProcessesBelgium
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
Universitair Ziekenhuis BrusselRecruitingIntubation Complication | Laryngeal Mask ComplicationBelgium
-
Universitair Ziekenhuis BrusselCompletedDeep Sedation | Post-cardiac Surgery | RASS-scoreBelgium
-
Hasselt UniversityJessa HospitalUnknownIncidence of Readmissions | ADE's Due to AnticoagulantsBelgium
-
KU LeuvenUnknownPatients With Adnexal Mass Prior to SurgeryBelgium
-
KU LeuvenUnknownPatients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple RulesBelgium
-
Blueprint Medicines CorporationCompletedSystemic Mast Cell Activation | KIT D816V MutationUnited States, France, United Kingdom, Italy, Germany, Belgium, Spain, Switzerland
-
Universitaire Ziekenhuizen KU LeuvenRecruitingPregnancy Related | Adnexal Mass | Adnexal Tumor | Adnexal CystBelgium
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
Cogent Biosciences, Inc.RecruitingAdvanced Systemic Mastocytosis (AdvSM) | SM With an Associated Hematologic Neoplasm (SM-AHN) | Mast Cell Leukemia (MCL) | Aggressive Systemic Mastocytosis (ASM)Norway, United States, Spain, Australia, United Kingdom, Switzerland, Germany, Belgium, Netherlands, Canada, France, Austria, Italy
-
Novartis PharmaceuticalsCompletedLeukemiaUnited States, Belgium, Netherlands, Canada, Austria, Germany, Australia, United Kingdom, Turkey, France, Poland, Norway
-
Blueprint Medicines CorporationRecruitingAdvanced Systemic MastocytosisUnited States, Norway, Netherlands, Belgium, Germany, France, Spain
-
PfizerBristol-Myers SquibbCompletedMSS | RAS-mutant Colorectal CancerUnited States, Spain, Belgium, United Kingdom, Netherlands
-
Blueprint Medicines CorporationActive, not recruitingIndolent Systemic MastocytosisCanada, United States, Spain, United Kingdom, Germany, Belgium, Switzerland, Italy, Netherlands, Denmark, France, Norway, Sweden
-
Amal TherapeuticsBoehringer IngelheimActive, not recruitingMetastatic Colorectal Cancer | Colorectal Cancer | Liver Metastasis Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | MSSUnited States, Belgium, Switzerland, Germany
-
Cogent Biosciences, Inc.RecruitingMastocytosis | Mastocytosis, Systemic | SSM | Mastocytosis, IndolentUnited States, Italy, Canada, Australia, Spain, Switzerland, Norway, United Kingdom, Belgium, Poland, Netherlands, Germany, France, Czechia, Greece, Ireland
-
Telios Pharma, Inc.RecruitingMyelofibrosis | Indolent Systemic MastocytosisUnited States, Spain, Belgium, Australia, Taiwan, Germany, Poland, Korea, Republic of, Hungary, Brazil, Bulgaria, France, Italy
-
Swedish Orphan BiovitrumRecruitingSystemic Lupus Erythematosus | Macrophage Activation Syndrome | Still Disease | Secondary Hemophagocytic Lymphohistiocytosis | SJIA | AOSD | MASUnited States, Belgium, Italy, Netherlands, United Kingdom, China, France, Spain, Czechia, Canada, Sweden, Japan, Germany, Poland
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore